Review

Prior art for the development of a fourth purification stage in wastewater treatment plant for the elimination of anthropogenic micropollutants-a short-review

  • Received: 29 September 2019 Accepted: 24 February 2020 Published: 27 February 2020

  • The ubiquitous presence of pharmaceuticals in the aquatic environment is a worldwide problem of today. Current analytical methods reveal ever more pharmaceuticals in different water bodies. The concentrations in waters that are detectable reach nano-and picogram ranges, i.e., ppb and ppt levels. Observed concentrations amount to as high as few micrograms. Among the major entry paths are wastewater treatment plants, which are often unable to eliminate the pharmaceuticals sufficiently relying on their three conventional purification stages. Hence, pharmaceuticals enter the aquatic environment without desirable deconstruction. Thus, advanced wastewater treatment processes are under development to retain or eliminate these trace contaminants. According to Decision 2018/840, a watchlist of 15 contaminants of significant interest has been established for the monitoring of surface waters in the European Union. The contaminants include biocides and pharmaceuticals, among them three estrogens, estrone (E1), 17-β-estradiol (E2) and 17-α-ethinylestradiol, (EE2), the antibiotics azithromycin, clarithromycin and erythromycin of macrolide type, ciprofloxacin and amoxicillin of fluoroquinolone and betalactame type. This review will provide an overview of the currently explored and researched methods for the realization of a fourth purification stage in wastewater treatment plants. To this purpose, biological, chemical and physical purification processes are reviewed and their characteristics and potential discussed. The degradation efficacy of the pharmaceuticals on the EU-Watch list will be compared and evaluated with respect to the most promising processes, which might be realized on large scale. Last but not least, recent and novel pilot plants will be presented and discussed.

    Citation: Melanie Voigt, Alexander Wirtz, Kerstin Hoffmann-Jacobsen, Martin Jaeger. Prior art for the development of a fourth purification stage in wastewater treatment plant for the elimination of anthropogenic micropollutants-a short-review[J]. AIMS Environmental Science, 2020, 7(1): 69-98. doi: 10.3934/environsci.2020005

    Related Papers:

    [1] Jianfeng Wen, Yanjin Liu, Yunjie Tu and Mark W. LeChevallier . Energy and chemical efficient nitrogen removal at a full-scale MBR water reuse facility. AIMS Environmental Science, 2015, 2(1): 42-55. doi: 10.3934/environsci.2015.1.42
    [2] Abigail W. Porter, Sarah J. Wolfson, Lily. Young . Pharmaceutical transforming microbes from wastewater and natural environments can colonize microplastics. AIMS Environmental Science, 2020, 7(1): 99-116. doi: 10.3934/environsci.2020006
    [3] Volodymyr Ivanov, Viktor Stabnikov, Chen Hong Guo, Olena Stabnikova, Zubair Ahmed, In S. Kim, and Eng-Ban Shuy . Wastewater engineering applications of BioIronTech process based on the biogeochemical cycle of iron bioreduction and (bio)oxidation. AIMS Environmental Science, 2014, 1(2): 53-66. doi: 10.3934/environsci.2014.2.53
    [4] Frank Abimbola Ogundolie, Olorunfemi Oyewole Babalola, Charles Oluwaseun Adetunji, Christiana Eleojo Aruwa, Jacqueline Njikam Manjia, Taoheed Kolawole Muftaudeen . A review on bioremediation by microbial immobilization-an effective alternative for wastewater treatment. AIMS Environmental Science, 2024, 11(6): 918-939. doi: 10.3934/environsci.2024046
    [5] Liron Shoshani, Asher Brenner, Chaim Sheindorf . Use of an integrated biophysical process for the treatment of halo- and nitro- organic wastes. AIMS Environmental Science, 2017, 4(4): 523-539. doi: 10.3934/environsci.2017.4.523
    [6] Joyce Cristale, Silvia Lacorte . PBDEs versus NBFR in wastewater treatment plants: occurrence and partitioning in water and sludge. AIMS Environmental Science, 2015, 2(3): 533-546. doi: 10.3934/environsci.2015.3.533
    [7] Luigi Falletti, Lino Conte, Andrea Maestri . Upgrading of a wastewater treatment plant with a hybrid moving bed biofilm reactor (MBBR). AIMS Environmental Science, 2014, 1(2): 45-52. doi: 10.3934/environsci.2014.2.45
    [8] Vera Barbosa, Madalena Morais, Aurora Silva, Cristina Delerue-Matos, Sónia A. Figueiredo, Valentina F. Domingues . Comparison of antibiotic resistance in the influent and effluent of two wastewater treatment plants. AIMS Environmental Science, 2021, 8(2): 101-116. doi: 10.3934/environsci.2021008
    [9] Rafael Gonzalez-Olmos . Leading edge technologies in wastewater treatment. AIMS Environmental Science, 2015, 2(2): 237-240. doi: 10.3934/environsci.2015.2.237
    [10] Xiaojun Liu, Ikbel Souli, Mohamad-Amr Chamaa, Thomas Lendormi, Claire Sabourin, Yves Lemée, Virginie Boy, Nizar Chaira, Ali Ferchichi, Pascal Morançais, Jean-Louis Lanoisellé . Effect of thermal pretreatment at 70 °C for one hour (EU hygienization conditions) of various organic wastes on methane production under mesophilic anaerobic digestion. AIMS Environmental Science, 2018, 5(2): 117-129. doi: 10.3934/environsci.2018.2.117

  • The ubiquitous presence of pharmaceuticals in the aquatic environment is a worldwide problem of today. Current analytical methods reveal ever more pharmaceuticals in different water bodies. The concentrations in waters that are detectable reach nano-and picogram ranges, i.e., ppb and ppt levels. Observed concentrations amount to as high as few micrograms. Among the major entry paths are wastewater treatment plants, which are often unable to eliminate the pharmaceuticals sufficiently relying on their three conventional purification stages. Hence, pharmaceuticals enter the aquatic environment without desirable deconstruction. Thus, advanced wastewater treatment processes are under development to retain or eliminate these trace contaminants. According to Decision 2018/840, a watchlist of 15 contaminants of significant interest has been established for the monitoring of surface waters in the European Union. The contaminants include biocides and pharmaceuticals, among them three estrogens, estrone (E1), 17-β-estradiol (E2) and 17-α-ethinylestradiol, (EE2), the antibiotics azithromycin, clarithromycin and erythromycin of macrolide type, ciprofloxacin and amoxicillin of fluoroquinolone and betalactame type. This review will provide an overview of the currently explored and researched methods for the realization of a fourth purification stage in wastewater treatment plants. To this purpose, biological, chemical and physical purification processes are reviewed and their characteristics and potential discussed. The degradation efficacy of the pharmaceuticals on the EU-Watch list will be compared and evaluated with respect to the most promising processes, which might be realized on large scale. Last but not least, recent and novel pilot plants will be presented and discussed.



    Abbreviations: AOP: Advanced oxidation process; BDD: boron-doped diamond electrodes; CW: Constructed wetland; E1: Estrone; E2: 17-beta-estradiol; EE2: 17-alpha-Ethinylestradiol; EU: European Union; GAC: Granulated activated carbon; H-SSF: horizontal subsurface flow; MBR: membrane bioreactor; MP: micropollutant; MWCO: Molecular Weight Cut Off; PAC: Powdered activated carbon; PNEC: predicted no effect concentration; SF: Surface flow; TOC: Total organic carbon; UF: Ultrafiltration; USA: United States of America; UV: Ultra violet; V-SSF: vertical subsurface flow; WWTP: wastewater treatment plant

    The extensive contamination of natural water resources and the aquatic environment with anthropogenic micropollutants (MPs) has come into the focus of public attention in recent years [1,2,3]. Such MPs comprise many different categories of substances like microparticles and molecular compounds [4,5]. Among the latter are biocides, which are toxic by nature, but also pharmaceutical drugs, which have now been used for decades in human and veterinary medicine [5]. Yet, these drugs or their metabolites reach the aquatic environment through excretion preceded by administration and through disposal [6,7]. Particular concern has been given to antibiotics in the environment leading to resistance and thus hindering the curing of diseases [8,9].

    Currently, wastewater treatment plants (WWTPs) are not yet fully prepared for these new challenges. They have only insufficient possibilities at their disposal for the removal of MPs, such as pharmaceuticals or personal care products [10,11,12]. A variety of MPs is able to pass non-degraded and unhindered through the conventional purification stages of a WWTP. Further to a brief introduction to the design and functioning of a WWTP, this review presents various technological options for advanced wastewater treatment. These include advanced biological, physical and chemical treatment processes, which are presented according to their mode of operation, areas of application and realization. The realization outside and above the laboratory scale, i.e., in the form of pilot-scale systems, will receive special attention. Due to their importance and the many sources of ecological hazard, the review focuses on the elimination of pharmaceuticals from wastewater. The selectively chosen pharmaceuticals are found on the current European Union (EU) watchlist 2018/840 [13].

    Further regulations of these trace substances have been introduced or extended during the last decade. One of them is the Decision 2018/840, which contains a watch list of critical substances for EU wide monitoring [13]. The first directive for the European water policy was published in 2000 whose main aim was to define a strategy to identify and prioritize high risk substances [14]. The first watch list was published in 2008 as the Directive 2008/105/EC, which comprised a set of 33 priority substances or groups of substances. The corresponding environmental quality standards were ratified [15]. The following Directive 2013/39/EU recommended 45 priority substances for monitoring in water systems to protect the aquatic compartments and the human health [16]. In 2015, the EU watchlist for monitoring was reduced to 17 organic compounds. The current list as of 2018 contains merely 15 organic trace substances [13,17]. Among these organic substances, there are 7 pharmaceutically used drugs, cf. Table 1.

    Table 1.  Pharmaceuticals of the EU watchlist, decision 2018/840.
    Group Substance CAS-number Structure
    Estrogenes 17-alpha-Ethinylestradiol (EE2) 57-63-6
    17-beta-estradiol (E2) 50-28-2
    Estrone (E1) 53-16-7
    Beta-Lactam Amoxicillin 26787-78-0
    Fluoroquinolone Ciprofloxacin 85721-33-1
    Macrolides Azithromycin 83905-01-5
    Erythromycin 114-07-8
    Clarithromycin 81103-11-9

     | Show Table
    DownLoad: CSV

    Their presence in different kinds of water, especially surface, ground and drinking water was proved in several studies. A summary of these studies is shown in Table 2. Concentrations were found to depend on the global region. Values in Table 2 are reported as the highest concentrations observed in surveys, which were collected in a database of the Federal Environment Agency, Germany [18]. The listed values date from the period 2005 to 2018. For some compounds, such as ciprofloxacin and erythromycin in groundwater, concentrations found decreased towards the end of this period.

    Table 2.  Pharmaceuticals on the EU watchlist in the aquatic environment in surface, ground and drinking water; country of observation given in brackets. Data collected from the database of the Federal Environment Agency, Germany [18].
    Substance Surface water ng/L Ground water ng/L Drinking water ng/L
    17-alpha-Ethinylestradiol (EE2) 17.9 (Germany)
    99 (USA)
    27.4 (China)
    11.7 (Turkey)
    150 (Brazil) 19.5 (Taiwan)
    230 (USA)
    22.5 (Germany)
    1822 (Taiwan)
    154 (Brazil)
    0.35 (Germany)
    17-beta-estradiol (E2) 17.28 (China)
    250 (USA)
    369 (Argentina)
    147 (USA) 2.1 (Germany)
    14 (Denmark)
    33 (Brazil)
    Estrone (E1) 5.74 (Turkey)
    69.05 (Republic of Korea)
    13.7 (France)
    107 (Canada)
    200 (USA)
    321 (China)
    14.9 (Taiwan)
    10 (South Africa)
    90 (France)
    12.7 (Denmark)
    Amoxicillin 552 (United Kingdom)
    63.9 (Turkey)
    31.9 (USA)
    127.8 (Greece)
    0.1 (Germany)
    5 (Spain)
    -
    Ciprofloxacin 187 (China)
    142.7 (Republic of Korea)
    40 (Spain)
    323.75 (Spain)
    71.1 (Canada)
    45 (USA)
    16.68 (China)
    13.28 (Spain)
    32 (Switzerland)
    31 (China)
    Azithromycin 81 (Serbia)
    836.2 (Japan)
    90.8 (Vietnam)
    138 (Spain)
    329 (Japan)
    1650 (USA)
    140 (Serbia)
    13.1 (China)
    48 (USA)
    80 (USA)
    Erythromycin 63.9 (Vietnam)
    65.1 (Spain)
    1613 (China)
    107 (South Africa)
    137 (Ghana)
    174.73 (Spain)
    154.33 (Spain)
    2380 (USA)
    154.33 (Spain)
    377.8 (China)
    54.8 (Taiwan)
    5 (USA)
    155 (Canada)
    490 (Germany)
    17.86 (China)
    Clarithromycin 17.6 (USA)
    85 (Germany)
    778 (Vietnam)
    88.83 (Spain)
    67.2 (Switzerland)
    180 (China)
    12.5 (Taiwan) 3.67 (Spain)
    11.9 (China)

     | Show Table
    DownLoad: CSV

    Yet, some of the values given seem rather high, such as groundwater concentration in Taiwan or in the US. Since the reports were evaluated reliable by authorities and experts, this might have been due to local over-application, unfavorable soil or weather conditions or avoidance of water treatment.

    No consistent trend could be recognized which countries/regions or which type of water were particularly at risk. All pharmaceuticals on the EU watchlist were found in varying concentrations throughout the world in different waterbodies.

    While all WWTPs have common features, there are also important differences. Every WWTP needs to be adapted to local conditions. These include the number of connected inhabitants, the type of waste water, e.g., municipal or industrial, the type and quantity of freight, the average amount of waste water but also seasonal variations. These requirements result in different modifications of WWTPs. It is common practice to summarize their structure by the linked purification stages. The stages are following their sequence mechanical, biological and chemical purification. Each stage is realized in a different way. Rakes, clarifiers, sand traps or combinations thereof serve as the mechanical purification stage. The biological stage acts as the main transformation and degradation level of dissolved waste components. Unspecified bacteria, but usually highly adapted and specific to the local freight, form the heart of the WWTP. In addition to the secondary clarifier, the biological stage consists of the activated sludge tank and the nitrification and denitrification. At last, precipitation reactions, such as pH adjustment and flocculation, are mainly used in the chemical stage. The sludge produced in the purification stages is treated separate from the wastewater. The various purification stages are linked together in the WWTP. A simplified schematic structure of a typical conventional WWTP is shown in Figure 1.

    Figure 1.  Schematic structure of a conventional WWTP.

    The mechanical stage in the WWTP consists of a raking system, a sand trap and a primary clarifier. The biological stage is subdivided into anaerobic treatment, denitrification and aeration basins. The chemical stage-after the secondary purification–acts as clarification and includes only addition of a phosphate precipitant as final clarifier. The precipitated phosphate sediments and is removed with the sludge. Some WWTPs may add a sand filtration stage for removal. The clarified wastewater is eventually discharged into a natural body of water. The contamination of the aquatic environment with biologically or ecotoxicologically active substances, such as antibiotics, has become known through various studies [19,20,21]. The route of substances into the environment is not always easy to understand. Yet, some studies suggest the sewage system as a major entry path of pharmaceuticals into the aquatic environment [22]. Jelic et al. investigated 43 pharmaceuticals in the inflow, outflow and sludge of the sewage treatment plants in three sewage treatment plants in Catalonia during eight sampling campaigns [22]. These WWTPs only had a biological stage in addition to the mechanical cleaning. One WWTP had a third stage in form of a flocculation basin. Of 43 pharmaceuticals sought, 32 were found in the influent, 29 in the effluent and 21 in the sludge. Diclofenac, carbamazepine, clarithromycin and sulfamethazine were among the substances that were detected in the influent, effluent and sludge. The concentrations were reported in the range of ng/L in the influent and effluent and ng/g in the sludge. This study and many more showed the need for development of a fourth purification stage in WWTPs worldwide [23,24,25,26].

    Table 3 provides an overview of concentrations of the relevant pharmaceuticals in effluents of WWTPs. The predicted no effect concentration (PNEC) is defined as the predicted concentration of a substance generally hazardous to the environment but has no environmental impact. As long as this concentration is not exceeded, no adverse environmental effects should occur. Due to the predictive nature of the value, reported PNEC may differ among studies.

    Table 3.  Overview of concentrations of pharmaceuticals from the EU watchlist in effluents of WWTPs worldwide and their determined PNECs.
    Substance Effluent conventional WWTP (ng/L)a) PNEC (ng/L)b)
    17-alpha-Ethinylestradiol (EE2) 4.5 (France)
    17.1 (China)
    8.9 (Germany)
    43 (USA)
    0.04
    17-beta-estradiol (E2) 4.2 (France)
    44.5 (China)
    40 (Germany)
    54.87 (USA)
    0.008
    Estrone (E1) 110 (Japan)
    165 (Germany)
    205 (Canada)
    107 (Australia)
    0.16
    Amoxicillin 147 (Germany)
    283 (Spain)
    190 (Australia)
    1670 (China)
    0.78
    Ciprofloxacin 2950 (Republic of Korea)
    591 (Greece)
    5692 (Spain)
    199 (China) 720 (Australia)
    810 (Columbia)c
    500
    Azithromycin 1890 (Spain)
    728 (China)
    1149 (Croatia)
    850 (Germany)
    350 (USA) 3990 (Columbia)c
    19
    Erythromycin 294 (Republic of Korea)
    6316 (Spain)
    35 (Canada)
    611 (USA)
    44 (Columbia)c
    400
    Clarithromycin 112 (USA)
    780 (Sweden)
    970 (Germany)
    996 (Croatia)
    420 (Canada) 310 (Columbia)c
    40
    Notes: a: Database of the Federal Environment Agency, Germany [18]; b: Orias and Perrodin [27]; c: Botero-Coy et al. [28].

     | Show Table
    DownLoad: CSV

    According to the studies collected in the German Federal Environment Agency database, concentrations of pharmaceuticals found in conventional WWTPs exceeded the PNEC. It can hence be assumed that there is indeed a risk to the aquatic environment, to its species and to humans. There is a need for installation of a fourth purification stage in conventional WWTPs. Research and realization approaches for an extended cleaning stage will be presented in the following chapters.

    Various technologies for potential use as a fourth purification stage in WWTPs have emerged from research and development [7,29,30,31]. These may be subdivided into biological, chemical and physical treatment processes. The processes can also be combined with each other in many ways. In the following paragraphs, the individual processes are presented with particular emphasis on their functionality and their efficacy to eliminate pharmaceuticals from wastewater.

    Among the biological purification processes, two approaches are of major importance: Constructed wetlands (CWs) and membrane bioreactors (MBRs) [29,32,33]. Wastewater processing systems of CW type are based on shallow ponds, beds or trenches containing floating or emerging rooted wetland vegetation [34,35]. The polluted water passes through the vegetation field and purification is achieved through gravity inducement. Depending on their construction, CWs are divided into three classes: Surface flow (SF), horizontal subsurface flow (H-SSF) and vertical subsurface flow (V-SSF) [36,37,38]. A schematic representation of the different classes of CWs is shown in Figure 2.

    Figure 2.  Scheme of mode of operation of CWs: a): SF, b) H-SFF and c) V-SFF.

    The simplest of the CW construction is the SF [39]. Wastewater is discharged into a plant-inhabited lake. It is cleaned through the plants. The purified water flows out of the lake. Dirt particles sediment–driven by gravity–to the bottom and into the substrate. Within the arrangement of H-SFF, the water is passed horizontally through a pipe onto the appropriate substrate, penetrates several layers and is thereby cleaned [36]. The purified water is discharged through a pipe at the borders of the CW. In the V-SFF, the wastewater is transferred vertically through several tubes into the CW and onto the substrate where it drains away through the substrate layers [36]. The purified water is finally recovered and collected on the bottom of the CW from where it is discharged.

    Owing to the different methods, pharmaceuticals can be eliminated from the water. The efficiency of each procedure is shown in Table 4.

    Table 4.  Removal efficiency of the pharmaceuticals for CW of type SF, H-SSF and V-SSF given as percentage.
    Substance SF % H-SSF % V-SSF %
    17-alpha-Ethinylestradiol (EE2) 76a 84a 75b
    17-beta-estradiol (E2) 77a 85a 84b
    Estrone (E1) 97e 89e 68b
    Ciprofloxacin 100f 67d 82–85
    Amoxicillin 27–42c 6–2c
    Azithromycin 86d
    Erythromycin 62f 64c
    Clarithromycin 11–32c 39c
    Notes: a: Dai et al. [40]; b: Song et al. [41]; c: Hijosa-Valsero et al. [38]; d: Verlicchi et al. [42]; e: Song et al. [43]; f: Hu et al. [44].

     | Show Table
    DownLoad: CSV

    The best degradation efficiencies were achieved using the V-SSF-system. Seasonal differences in degradation efficiency were also reported. The removal or elimination of individual substances by means of CWs deteriorates significantly from summer to winter [40]. Complete elimination could not be achieved except for ciprofloxacin while removal efficiencies seemed promising in particular for estrogens. Considering the overall efficiency for the watchlist pharmaceuticals, the H-SSF approach performed best. In addition, CW realization is an easy, relatively inexpensive and efficient method with respect to the purity of the effluent.

    Another biological treatment process makes use of MBR. The technique could be described as ultrafiltration [45,46]. A variety of membranes are available. Differences in the processes originate from the membrane materials used and the pore sizes of the membranes [47,48]. Separation takes place by size exclusion or by different solution and diffusion behavior. Therefore, pore and solution diffusion membranes are distinguished. While the latter allow mass transfer by diffusion, pore membranes control the mass flow through pore and contaminant size. To classify membranes, the minimum molecular size, that is still retained, is usually indicated as the Molecular Weight Cut Off (MWCO) [49]. With decreasing pore size of the membranes, thus with decreasing MWCO, the transmembrane pressure where the processes must be operated increases. This defines the pressure difference between inlet and permeate side [49]. An overview of the physical processes with the corresponding MWCO, membrane types and transmembrane pressures is given in Table 5.

    Table 5.  Overview of different membrane process [49].
    Membrane processes Pore size/MWCO Transmembrane pressure
    Microfiltration 0.1–1 µm /- < 3 bar
    Ultrafiltration (UF) 0.004–0, 1 µm /2.000–200.000 Da < 10 bar
    Nanofiltration -/ > 200 Da 5–40 bar
    reverse osmosis -/200 Da 5–70 bar

     | Show Table
    DownLoad: CSV

    Two different installations in combination with the MBR are used: Sidestream and submerged MBR, see Figure 2 [45,50,51].

    Figure 2.  MBR as a) sidestream and b) submerged treatment process.

    In the sidestream MBR installation, the water to be purified is flowed into a bioreactor where it is aerated for aerobic decomposition of the substances. The water is further passed through an externally installed membrane compartment, where additional cleaning takes place. Pollutants are recirculated back into the bioreactor. Purified water leaves the system as effluent.

    In contrast to the sidestream processes, the membrane purification step in a submerged MBR is integrated into the bioreactor such that purified water is obtained directly from the reactor. The efficiencies of the two reactor types for the purification process are shown in Table 6.

    Table 6.  Comparison of the purification efficiency of sidestream MBR and submerged MBR systems for the pharmaceuticals on the EU-watchlist.
    Substance Sidestream MBR % Submerged MBR %
    17-alpha-Ethinylestradiol (EE2) 87a
    17-beta-estradiol (E2) 99a 90c
    Estrone (E1) 100a < 10b
    Ciprofloxacin 93b 64d
    Amoxicillin 100e
    Azithromycin 90e 100d
    Erythromycin 89a < 60d
    Clarithromycin 75e 62d
    Notes: a: Besha et al. [52]; b: Cecconet et al. [33]; c: Fan et al. [53]; d: Kovalova et al. [54]; e: Le et al. [55].

     | Show Table
    DownLoad: CSV

    Nearly independent from the pharmaceuticals, the sidestream MBR proved the better approach for purification. For the most part, cleaning efficiencies of over 90% were achieved. On comparison to the CWs, the sidestream MBR showed higher removal efficiencies. Its design is less space demanding since it is of much smaller dimensions.

    Nevertheless, some draw-backs are associated with MBRs. Pore sizes of the membrane can change over time due to the addition of substances, a process referred to as membrane fouling [51,56,57]. The effect can be sufficiently strong that microfiltration becomes ultrafiltration [56]. Especially during the filtration of water, microorganisms preferably attach to the membrane, as nutrients are carried directly and continuously to them. When growth of bacteria on the membrane persevers, complete clogging or blocking of the membrane occurs. This is called biofouling [58]As another undesired aspect, molecular entities are not retained even in case of ultrafiltration.

    A promising way to eliminate anthropogenic MPs is the use of Advanced Oxidation Processes (AOPs) [19,59,60,61,62]. These include the irradiation of solutes with UV light, which can be carried out with the addition of hydrogen peroxide (H2O2) or titanium dioxide (TiO2), catalyzing and accelerating the elimination. Other AOPs comprise ozonation, sonolysis, photoelectrocatalytic reactions or photo-Fenton processes.

    Defining element of AOPs is the generation of hydroxyl radicals. These radicals have the highest oxidation potential, i.e., 2.80 V, second only to fluorine, 3.03 V [59,60,63]. Hydroxyl radicals can be generated by various methods during AOPs, see Figure 3.

    Figure 3.  Overview of common AOPs; BDD = boron−doped diamond electrodes.

    Ideally, complete mineralization of the MPs according to Eq 1 occurs, which reduces or eliminates toxicity [59,64,65,66].

    CnHmXz+O2hvnCO2+(mz)2H2O+zHX (1)

    with X:NO3, SO4, Cl, Br, I

    When these compounds do not contain halides, their degradation can be described according to Eq 2 [67].

    CxHyNlOmSn+(x+14y+54l+12m+32n)O2hvxCO2+lHNO3+nH2SO4+12(yl2n)H2O (2)

    The formation of products more toxic than the initial pharmaceutical has been discussed as disadvantage of AOPs using photo-irradiation [68,69]. Thus, it is important to carry out the irradiation until complete mineralization of the pharmaceutical or at least to the point where no toxic or reactive species persists.

    During sonolysis, hydroxyl radicals are generated from water and may recombine to hydrogen peroxide. Firstly, ultrasonic waves consist of expansion and compression cycles. During expansion, these waves possess sufficient intensity to form bubbles within liquids. Secondly, these bubbles continuously absorb energy from the expansion and compressions cycles. The bubbles grow to a critical size and collapse. During collapsing, a high local temperature of about 5000 K occurs together with a high pressure of about 1000 atm [70,71]. Under these conditions, water molecules dissociate. The formation of OH radicals is frequency dependent with a maximum formation rate at sonic frequencies between 200–350 kHz [71]. Addition of iron induces the Fenton process [72]. Serna-Galvis et al. studied different systems. Three macrolide compounds were removed from WWTP effluent on average of 65% after 90 minutes of treatment [72]. When sonolysis, UV irradiation, oxalic acid and Fenton reagents were combined, a reduction of 72% was achieved within 90 min.

    The intensely researched AOPs comprise ozonation and UV light irradiation, which are discussed in more detail in this chapter. With the help of vacuum UV radiation, i.e., in the range of 100–200 nm, it is possible to dissociate water into OH radicals, see Eq 3 [59,73,74,75,76].

    H2Ohv(<200 nm)H2OH+OH (3)

    The oxygen content in solution may also influence a reaction under UV irradiation [67,77]. In the presence of oxygen, the hydrogen radical, which is formed together with the hydroxyl radical from water at 185 nm irradiation, can react with oxygen to form the peroxyl radical, see Eq 4 [75].

    O2+HHO2 (4)

    Depending on the UV responsiveness of a substance, compounds can be degraded using UV irradiation [62,78]. The degradation can be further accelerated using H2O2 or TiO2, see Eqs 5 and 6.

    H2O2hvH2O22OH (5)
    TiO2hve+h+ (6)

    In case of UV irradiation, sufficient radiation intensity, many times rather high intensity, is a prerequisite for successful photo-induced degradation. Many substances can be degraded provided the penetration depth or the radiation into the solution and the irradiation time are sufficient. The degradation can also be accelerated by using homogeneous or heterogeneous catalysts. Up-scaling or piloting of AOPs is often hindered or impeded by the complex wastewater matrix absorbing large fractions of the radiation, rendering the catalysts inefficient through adsorption or scavenging the hydroxyl radicals.

    Ozone is an unstable, reactive oxidant and must be produced on-site in a high-voltage alternating field due to its poor storage stability. The ozone thus produced is introduced into the wastewater stream after the biological purification stage and oxidizes substances present directly or indirectly, i.e., it generates hydroxyl radicals through reaction with water molecules. Owing to the reactivity of ozone, the occurring reactions are rather unspecific. Hence, a wide variety of products can arise. An overview of the direct and indirect ozone reaction pathways is given in Figure 4 [79].

    Figure 4.  Direct and indirect reaction pathways of ozone in waste water treatment systems.

    The ozone dosage is essential for the degradation efficiency [80]. In principle, any organic substance can be degraded completely if the dosage of ozone is sufficient. Yet, the wastewater matrix always containing oxidizable material of biological, biochemical or non-anthropogenic chemical origin acts as buffer for direct and indirect ozonation, requiring thus an even higher ozone dose than necessary for pharmaceutical micropollutants.

    Processes using as oxidant ozone in combination with H2O2 and UV irradiation are known to accelerate the degradation of pharmaceuticals [59,60,81,82].

    As examples, azithromycin and erythromycin at a concentration of 20 mg/L were degraded within 10 min by UVC irradiation [62,78]. The degradation rate was found accelerated in the presence of H2O2 [78]. Studies by Tong et al. showed a slower degradation rate [83]. Azithromycin was irradiated during several hours but complete degradation could still not be achieved within one day. Only the use of artificial water and the addition of nitrate and humic acid led to complete degradation [83]. This was due to using different radiation sources, in case of the latter study more similar to sunlight.

    Similar results were reported for EE2. Frontistis et al. compared the use of sources radiating exclusively either in the UVA or the UVC region with solar irradiation [84]. Within 60 min, complete degradation of 100 µg/L EE2 could not be achieved. Best results were observed from UVC irradiation, where the degradation efficiency amounted to 47%. Using 10 mg/L H2O2 complete removal of EE2 was obtained within 15 min [84]. Ma et al. achieved complete degradation of EE2 in 120 min in the presence of 15 mg/L H2O2 [85]. Similar results were reported for E2. In case of E1 complete degradation was found within 60 min in the absence of H2O2 [85]. The use of sources emitting different ranges and intensities yields different degradation efficiencies. The same applies for the type of water, e.g., pure model water, hospital wastewater, influent or effluent from WWTPs. Mostly the degradation of the active substance is slower in effluents of WWTP than in ultrapure water [67,86]. Several studies report the photon flux of the radiation source, which may allow for better comparison between studies [73]. Yet, others do not. Another critical point is that many studies deal with higher concentration of the active substance in their experiments than the concentrations in surface water found. Most often, the degradation efficiency refers to the main drug substance, leaving potentially ecotoxicological degradants. Only studies conducting total organic carbon (TOC) determination or at least dissolved organic carbon (DOC) follow the efficiency up to mineralization. Degradation or transformation products may best be identified by high-resolution liquid chromatography coupled to high-resolution mass spectrometry [62,78,86,87,88]. Bobu et al. investigated degradation rates of ciprofloxacin using ozone, UV irradiation, H2O2 and Fe(Ⅱ) individually and in combination [89]. The least TOC, hence best compound removal was achieved by combined UV irradiation, ozonation, hydrogen peroxide and Fe (II) treatment at a success rate of 93%. It could be shown that the different combinations of AOPs provide different degrees of degradation, requiring still further research in this topic. It should be noted that not only the degradation products resulting from these processes might be more toxic than the initial drug substance but ozone itself is also hazardous. That property renders the safety measures for use in WWTPs more costly and challenging.

    Physical processes use absorbents for purification, for example active carbon, carbon nanotubes or graphene-based nanomaterials [1,90,91,92]. The processes are based on the principle of adsorption, e.g., attachment to a surface-active solid such as resins or activated carbon. The adsorption is favored by the large specific internal surface of the adsorbent. Two mechanisms of sorption are distinguished: Chemisorption and physisorption. Chemisorption refers to an irreversible chemical reaction forming chemical bonding between adsorbent and adsorptive, while physisorption is based on van der Waals forces and therefore mostly reversible. In the liquid phase, the physisorption predominates and thus enables the regeneration of the adsorbent. Schematically, the processes during adsorption are shown in Figure 5.

    Figure 5.  Adsorption process of MP in waste water.

    One of the adsorbents the most used for wastewater purification is activated carbon [5,93]. Different types of activated carbons are available. Granulated activated carbon (GAC) and powdered activated carbon (PAC) are particularly suitable for use in WWTPs due to the large specific internal surface area and their ability to adsorb organic substances [5]. GAC and PAC differ in grain size. GAC has grain sizes up to 4 mm, while PAC has grain sizes up to 0.5 mm [94]. Hence, specific applications result. PAC is usually added to the wastewater stream before the secondary clarifier. Adsorption takes place during residence in the secondary clarifier and during subsequent filtration. The filtered PAC can be reused until a maximum load is reached. In contrast, GAC is commonly used as fixed-bed filters. Fix-bed filters are vertically arranged columns filled with absorbent as stationary phase. These are flowed through in upflow or downflow mode. To prevent a breakthrough of the adsorptive, the beds must be regenerated regularly. This is achieved by backwashing the adsorbent filter with a suitable washing solution. For the timely detection of an imminent breakthrough of the fixed-bed filters, the filtrate needs to be constantly monitored or regularly analyzed. The use of either PAC or GAC leads to removal efficiencies as listed in Table 7.

    Table 7.  Removal efficiency of PAC and GAC purification for EU watchlist pharmaceuticals.
    Substance PAC % GAC %
    17-alpha-Ethinylestradiol (EE2) 57e > 43a
    17-beta-estradiol (E2) 44e > 43a
    Estrone (E1) 49e 90c
    Ciprofloxacin 100b 95c
    Amoxicillin
    Azithromycin 100b
    Erythromycin > 95b 78c
    Clarithromycin 100b
    Notes: a: Grover et al. [95]; b: Kovalova et al. [96]; c: Mailer et al. [97]; e: Lima et al. [98].

     | Show Table
    DownLoad: CSV

    Complete removal by PAC was achieved for antibiotics [96]. Almost half of the content of estrogenic substances could be eliminated, which in principle is insufficient for water purification due to the high activity of these compounds. The efficiency could not be improved by use of GAC. For ciprofloxacin, erythromycin and azithromycin, very good elimination rates were found.

    Growing in size and numbers, investigative wastewater treatment studies are transferred from the laboratory scale to the scale of pilot plants, while WWTPs are equipped with an additional purification stage [99]. The use of the purification methods presented above are implemented fully or in part as pilot-scale installations in WWTPs. In particular, some WWTPs have been equipped with activated carbon, ozonation, MBR and/or UV irradiation as advanced purification stage. Several studies have taken into account economic factors and compared the procedures with each other. Here, Kå relid et al. constructed and compared two pilot plants for wastewater treatment using PAC and GAC [100]. The GAC pilot plant consisted of two tanks with a volume of approximately 60 L. The GAC filling height amounted to 1 m and was operated in a downflow configuration. The PAC pilot plant consisted of a mixing tank where the wastewater stream was mixed with PAC and subsequently homogenized. The installation was extended by three contact tanks with a volume of about 100 L. A sedimentation tank with a volume of about 180 L followed. A sand filtration tank concluded the assembly. It has a volume of about 66 L. A scheme of the pilot plant is given in Figure 6.

    Figure 6.  Scheme of the pilot-plant using A) GAC and B) PAC [100].

    For monitoring purposes, samples were taken at each tank's inlet and outlet. These were examined for various pharmaceuticals and their removability from the water. Apart from other pharmaceuticals, clarithromycin was investigated with respect to the removal efficiency. The elimination efficiencies were as high as 97% for PAC and 96% for GAC [100]. The use of PAC and GAC in pilot scale plants significantly increased the degree of elimination of clarithromycin and also other pharmaceuticals. When the results of the PAC pilot plant are compared to those of the GAC testing plant, similar successes were observed. Yet, elimination rates differed significantly, depending on the substance monitored. For example, carbamazepine was significantly better removed from wastewater using GAC in the pilot plant than using PAC. Other pharmaceuticals, such as diltiazem, were better eliminated from the water using PAC [100]. It must be noted that activated carbons show a great heterogeneity in affinity towards the variety of micropullutants depending on the specific manufacturing method [101]. Hence, in a meta-analysis of 44 pilot plant studies testing granular activated carbon treatment single adsorbers operating time was found to differ by 2500% due to the heterogeneity of these studies [102]. Besides activated carbon type these are DOC and process parameters as backwashing cycles. Overall, the use of the PAC pilot plant would remove over 18 of 22 pharmaceuticals by more than 95%. The GAC pilot plant achieved this efficiency for 9 out of 22 substances [100].

    Margot et al. investigated a pilot plant using PAC filtration and an additional ultrafiltration stage especially for the elimination of pharmaceuticals from wastewater, see Figure 7 [103].

    Figure 7.  Pilot plant using PAC absorption and an additional ultrafiltration stage [103].

    This fourth stage pilot plant was operated receiving water from the WWTP in Lausanne, Switzerland, for further cleaning. The pilot plant consisted of three contact reactors. Fresh PAC was suspended in already purified water, i.e., recirculated after purification, in the mixing vessel. The slurry was added to the water in the biological stage of the WWTP. The combined fraction was transferred into the contact reactors. In a vessel equipped with ultrafiltration membranes, PAC was separated from the water. One part of the carbon was recycled while the surplus was incinerated. By use of the PAC pilot plant the concentration of pharmaceuticals could be reduced by an average of 70% [103,104]. Margot et al. went on to use an ozonation pilot plant consisting of an ozonation reactor, ozone generator and sand filter, see Figure 8.

    Figure 8.  Ozonation pilot plant according to Margot et al. [103].

    The ozone was introduced via reversed flow, divided into four chambers. A sand filter acted as last stage before the effluents entering Lake Geneva. Excess gaseous ozone was catalytically destroyed in the exhaust air. The ozonation pilot plant was found to have a higher efficiency in the elimination of individual substances, while the PAC pilot plant was able to remove a wider range of substances [103,104]. A comparison between PAC-UF and Ozone removal efficiency is given in Table 8.

    Table 8.  Comparison of the pharmaceuticals removal efficiency using PAC-UF and Ozone and conventional WWTP [103,104].
    Substance PAC-UF % Ozone %
    17-alpha-Ethinylestradiol (EE2) - -
    17-beta-estradiol (E2) > 61 > 61
    Estrone (E1) > 92 > 90
    Ciprofloxacin 63 (±32) 53 (±29)
    Amoxicillin - -
    Azithromycin 76(±8) 74 (±10)
    Erythromycin - -
    Clarithromycin 92 (±5) 93 (±4)

     | Show Table
    DownLoad: CSV

    Both methods achieved the same degradation or removal efficiencies. Yet, complete degradation or elimination of all substances could not be achieved. An alternative approach was suggested where the ozonation step was interposed between the first aeration tank and the subsequent denitrification as described by Baresel et al., see Figure 9 [105].

    Figure 9.  Diagram of the pilot WWTP of Baresel et al. [105].

    Yet, the high oxygen concentration after ozonation as well as potential deleterious effects on the denitrification stage and on the environment persisted. Common pharmaceuticals, such as metoprolol, diclofenac and carbamazepine, were effectively eliminated from the water as a function of ozone concentration by the pilot plant. At an ozone concentration of 0.5 to 0.8 O3/mg dissolved organic carbon, the pharmaceuticals were reduced to a safe concentration level. Based on this data, a conversion of the WWTP in Linköping, Sweden, has been planned since 2015 [105].

    Mamo et al. expanded their WWTP by an optimized MBR in form of nanofiltration. The second purification stage was revised as well. The resulting pilot plant will be installed in WWTPs in Giron, Spain. Aim of the study by Mamo et al. was the reduction of pharmaceuticals that can form harmful products in a disinfecting step. These disinfection by-products include N-nitrosodimethylamine, which can be formed from azithromycin, clarithromycin or erythromycin [106]. The schematic structure of the MBR with nanofiltration according to Mamo et al. is visualized in Figure 10.

    Figure 10.  Schematic structure of the MBR by Mamo et al. [106].

    The macrolides, azithromycin, clarithromycin and erythromycin were reduced by about 62 to 100% using the MBR [106].

    Hofman-Caris et al. and Cédat et al. used various AOPs to reduce estrogens and pharmaceuticals in wastewater [107,108]. The construction of the pilot-plant from Cédat et al. is shown in Figure 11.

    Figure 11.  Schematic diagram of the pilot plant design by Cédat et al. [108].

    Without H2O2 addition, a maximum degradation of 70% was observed for the three estrogens. The higher the H2O2 concentration, the more efficient proved the degradation of E1, E2 and EE2. Here, 100% reduction was achieved by addition of 90 mg/L H2O2 [108].

    Hofman-Caris et al. compared the AOP combinations UV/H2O2, UV/O3 and O3/H2O2. The focus in this study was on the degradation of known pharmaceuticals. The different pharmaceuticals were degraded differently depending on the AOPs. The best results were attained by UV/O3 combination. Anhydroerythromycin A, which arises during degradation of erythromycin, was found degradable through all AOPs, except for the combination of O3 and H2O2 [107]. Thus, various combinations of AOPs are possible, the effectiveness differs from substance to substance.

    According to Margot et al., PAC and ozonation WWTPs may be run at comparable efficiencies and costs if the PAC system is equipped with a sand filter instead of an ultrafiltration system [104]. In general, the system used must be adapted to the wastewater which is to be treated. Further studies show the economy and efficiency of ozonation plants, but the required ozone concentration cannot be predicted and has to be determined in pilot experiments [109]. It will also vary with freight and season. Another problem with additional purification stages is an increased need for personnel. In addition to the need for additional staff, the necessary qualifications of the personnel employed increase depending on the technology used.

    When for example handling UV radiation, hydrogen peroxide or ozone, extended safety measures must be taken and personnel trained accordingly. Furthermore, all types of MPs need to be taken into account when choosing the additional purification stage, since further to pharmaceuticals, microplastics and nanoparticles carry a risk for the aquatic environment as well as for humans.

    The growing number of anthropogenic MPs in the aquatic environment occurs–among other pathways-through the sewage systems and thus WWTPs. Currently, only few WWTPs are able to remove organic MPs satisfactorily from wastewater. Chronically harmful substances not only enter the aquatic environment and negatively affect living organisms, but may also return eventually and occur in drinking water passing through water treatment plants. Yet, the problem does not lie only with current WWTPs but also with drinking water treatment plants, which often only filter or disinfect the water. As a secondary effect of the disinfection steps, harmful by-products such as N-nitrosodimethylamine may be generated from pharmaceuticals in the water treatment plants [106]. Besides the transformation products associated with the water treatment, human or animal metabolites of drug substances may also come into research focus, since their occurrence was observed in raw hospital wastewater that will eventually enter WWTPs [110].

    The increasing number of scientific or technological publications on wastewater treatment and the growing popular interest demonstrate that the problem has been identified and taken serious. The number of pilot plants being tested in WWTPs also indicates a growing public awareness.

    Several practical applications have advanced from the researched purification methods to the pilot plant level, such that the best technological choice for large-scale treatment plants seems within reach. However, the pilot plants are currently concentrated in very few areas over Europe. A geographical overview of pilot plants, not all of which were presented in this review, are shown in Figure 12.

    Figure 12.  Pilot-Plants in Europe using active carbon (black), MBR (red), ozonation (blue), AOPs (violet) and CWs (green).

    As can be recognized, such pilot plants are installed mainly in Western European countries. The highest concentration is actually found in Germany, Switzerland and Sweden. No pilot plants were reported from eastern European countries.

    While a variety of chemical processes work well on laboratory scale, scaling-up to pilot plant or even WWTP level causes severe technical and safety issues that need to be addressed. Cost efficiency also needs to be considered, giving often relatively less rigorous approaches such as CW purification an advantage. Nevertheless, feasibility and efficacy of PAC and ozonation combined with filtration techniques have already been proven successful.

    In the future, it will be necessary–and planning is under way in many countries-to equip more WWTPs with additional purification stages and to design new WWTPs accordingly. To this purpose, further research in the field of pilot plants needs to and will be carried out in order to evaluate the available and applicable technologies and to eventually protect our aquatic environment and ourselves.

    MV, KHJ and MJ gratefully acknowledge the financial support from EFRE.NRW, project Enz4Water (EFRE-0801523).

    All authors declare no conflicts of interest in this paper.



    [1] Tijani JO, Fatoba OO, Petrik LF (2013) A review of pharmaceuticals and endocrine-disrupting compounds: Sources, effects, removal, and detections. Water Air Soil Pollut 224.
    [2] Gerbersdorf SU, Cimatoribus C, Class H, et al. (2015) Anthropogenic Trace Compounds (ATCs) in aquatic habitats-Research needs on sources, fate, detection and toxicity to ensure timely elimination strategies and risk management. Environ Int 79: 85-105. doi: 10.1016/j.envint.2015.03.011
    [3] Burke V, Richter D, Greskowiak J, et al. (2016) Occurrence of Antibiotics in Surface and Groundwater of a Drinking Water Catchment Area in Germany. Water Environ Res 88: 652-659. doi: 10.2175/106143016X14609975746604
    [4] Schwarzenbach RP (2006) The Challenge of Micropollutants in Aquatic Systems. Science 313: 1072-1077. doi: 10.1126/science.1127291
    [5] Luo Y, Guo W, Ngo HH, et al. (2014) A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment. Sci Total Environ 473-474: 619-641. doi: 10.1016/j.scitotenv.2013.12.065
    [6] Haddad T, Baginska E, Kümmerer K (2015) Transformation products of antibiotic and cytostatic drugs in the aquatic cycle that result from effluent treatment and abiotic/biotic reactions in the environment: An increasing challenge calling for higher emphasis on measures at the beginning of the pi. Water Res 72: 75-126. doi: 10.1016/j.watres.2014.12.042
    [7] Rivera-Utrilla J, Sánchez-Polo M, Ferro-García MÁ, et al. (2013) Pharmaceuticals as emerging contaminants and their removal from water. A review. Chemosphere 93: 1268-1287. doi: 10.1016/j.chemosphere.2013.07.059
    [8] Kümmerer K (2009) Antibiotics in the aquatic environment-a review-part I. Chemosphere 75: 417-434. doi: 10.1016/j.chemosphere.2008.11.086
    [9] Novo A, Andre S, Viana P, et al. (2013) Antibiotic resistance, antimicrobial residues and bacterial community composition in urban wastewater. Water Res 47: 1875-1887. doi: 10.1016/j.watres.2013.01.010
    [10] Margot J, Rossi L, Barry DA, et al. (2015) A review of the fate of micropollutants in wastewater treatment plants. Wiley Interdiscip Rev Water 2: 457-487. doi: 10.1002/wat2.1090
    [11] Sui Q, Cao X, Lu S, et al. (2015) Occurrence, sources and fate of pharmaceuticals and personal care products in the groundwater: A review. Emerg Contam 1: 14-24. doi: 10.1016/j.emcon.2015.07.001
    [12] Du B, Price AE, Scott WC, et al. (2014) Science of the Total Environment Comparison of contaminants of emerging concern removal, discharge, and water quality hazards among centralized and on-site wastewater treatment system ef fl uents receiving common wastewater in fl uent. Sci Total Environ 466-467: 976-984. doi: 10.1016/j.scitotenv.2013.07.126
    [13] Decision 2018/840 (2018) Commission Implementing Decision (EU) 2018/840 of 5 June 2018 establishing a watch list of substances for Union-wide monitoring in the field of water policy pursuant to Directive 2008/105/EC of the European Parliament and of the Council and repealing Comm.
    [14] Directive 2000/60/EC (2000) Directive 2000/60/EC of the European Parliament and of the Council of 23 October 2000 establishing a framework for Community action in the field of water policy.
    [15] Directive 2008/105/EC Environmental quality standards applicable to surface water.
    [16] Directive 2013/39/EU Directive 2013/39/EU of the European Parliament and of the Council of 12 August 2013 amending Directives 2000/60/EC and 2008/105/EC as regards priority substances in the field of water policy Text with EEA relevance.
    [17] Decision 2015/495/EU Commission Implementing Decision (EU) 2015/495 of 20 March 2015 establishing a watch list of substances for Union-wide monitoring in the field of water policy pursuant to Directive 2008/105/EC of the European Parliament and of the Council (notified under.
    [18] aus der Beek T, Weber FA, Bergmann A, et al. (2016) Pharmaceuticals in the environment: Global occurrence and potential cooperative action under the Strategic Approach to International Chemicals Management (SAICM). UBA Texte 67/2016.
    [19] Gogoi A, Mazumder P, Kumar V, et al. (2018) Groundwater for Sustainable Development Occurrence and fate of emerging contaminants in water environment : A review. Groundw Sustain Dev 6: 169-180. doi: 10.1016/j.gsd.2017.12.009
    [20] Liu J, Dan X, Lu G, et al. (2018) Investigation of pharmaceutically active compounds in an urban receiving water: Occurrence, fate and environmental risk assessment. Ecotoxicol Environ Saf 154: 214-220. doi: 10.1016/j.ecoenv.2018.02.052
    [21] Zhang R, Zhang R, Yu K, et al. (2018) Occurrence, sources and transport of antibiotics in the surface water of coral reef regions in the South China Sea: Potential risk to coral growth. Environ Pollut 232: 450-457. doi: 10.1016/j.envpol.2017.09.064
    [22] Jelic A, Gros M, Ginebreda A, et al. (2011) Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment. Water Res 45: 1165-1176. doi: 10.1016/j.watres.2010.11.010
    [23] Biel-Maeso M, Baena-Nogueras RM, Corada-Fernández C, et al. (2018) Occurrence, distribution and environmental risk of pharmaceutically active compounds (PhACs) in coastal and ocean waters from the Gulf of Cadiz (SW Spain). Sci Total Environ 612: 649-659. doi: 10.1016/j.scitotenv.2017.08.279
    [24] Mirzaei R, Yunesian M, Nasseri S, et al. (2018) Occurrence and fate of most prescribed antibiotics in different water environments of Tehran, Iran. Sci Total Environ 619-620: 446-459. doi: 10.1016/j.scitotenv.2017.07.272
    [25] Paredes L, Omil F, Lema JM, et al. (2018) What happens with organic micropollutants during UV disinfection in WWTPs? A global perspective from laboratory to full-scale. J Hazard Mater 342: 670-678.
    [26] Kostich MS, Batt AL, Lazorchak JM (2014) Concentrations of prioritized pharmaceuticals in effluents from 50 large wastewater treatment plants in the US and implications for risk estimation. Environ Pollut 184: 354-359. doi: 10.1016/j.envpol.2013.09.013
    [27] Orias F, Perrodin Y (2013) Characterisation of the ecotoxicity of hospital effluents: A review. Sci Total Environ 454-455: 250-276. doi: 10.1016/j.scitotenv.2013.02.064
    [28] Botero-Coy AM, Martínez-Pachón D, Boix C, et al. (2018) 'An investigation into the occurrence and removal of pharmaceuticals in Colombian wastewater'. Sci Total Environ 642: 842-853. doi: 10.1016/j.scitotenv.2018.06.088
    [29] Wang B, Dai G, Deng S, et al. (2017) Large-scale enzymatic membrane reactors for tetracycline degradation in WWTP effluents. Water Res 45: 1-11.
    [30] Tiedeken EJ, Tahar A, McHugh B, et al. (2017) Monitoring, sources, receptors, and control measures for three European Union watch list substances of emerging concern in receiving waters-A 20 year systematic review. Sci Total Environ 574: 1140-1163. doi: 10.1016/j.scitotenv.2016.09.084
    [31] Oulton RL, Kohn T, Cwiertny DM (2010) Pharmaceuticals and personal care products in effluent matrices: A survey of transformation and removal during wastewater treatment and implications for wastewater management. J Environ Monit 12: 1956. doi: 10.1039/c0em00068j
    [32] Ahmed MB, Zhou JL, Ngo HH, et al. (2016) Progress in the biological and chemical treatment technologies for emerging contaminant removal from wastewater: A critical review. J Hazard Mater 323: 274-298.
    [33] Cecconet D, Molognoni D, Callegari A, et al. (2017) Biological combination processes for efficient removal of pharmaceutically active compounds from wastewater: A review and future perspectives. J Environ Chem Eng 5: 3590-3603. doi: 10.1016/j.jece.2017.07.020
    [34] Bayona JM (2013) Removal of Pharmaceutical Compounds from Wastewater and Surface Water by Natural Treatments. 62.
    [35] Cole S (1998) The Emergence of Treatment Wetlands. Environ Sci Technol 32: 218A-223A. doi: 10.1021/es9834733
    [36] Verlicchi P, Zambello E (2014) How efficient are constructed wetlands in removing pharmaceuticals from untreated and treated urban wastewaters? A review. Sci Total Environ 470-471: 1281-1306. doi: 10.1016/j.scitotenv.2013.10.085
    [37] Fountoulakis MS, Terzakis S, Chatzinotas A, et al. (2009) Pilot-scale comparison of constructed wetlands operated under high hydraulic loading rates and attached biofilm reactors for domestic wastewater treatment. Sci Total Environ 407: 2996-3003. doi: 10.1016/j.scitotenv.2009.01.005
    [38] Hijosa-Valsero M, Fink G, Schlüsener MP, et al. (2011) Removal of antibiotics from urban wastewater by constructed wetland optimization. Chemosphere 83: 713-719. doi: 10.1016/j.chemosphere.2011.02.004
    [39] Hijosa-Valsero M, Matamoros V, Martín-Villacorta J, et al. (2010) Assessment of full-scale natural systems for the removal of PPCPs from wastewater in small communities. Water Res 44: 1429-1439. doi: 10.1016/j.watres.2009.10.032
    [40] Dai Y, Dan A, Yang Y, et al. (2016) Factors Affecting Behavior of Phenolic Endocrine Disruptors, Estrone and Estradiol, in Constructed Wetlands for Domestic Sewage Treatment. EnvironSciTechnol 50: 11844-11852.
    [41] Song H, Nakano K, Taniguchi T, et al. (2009) Estrogen removal from treated municipal effluent in small-scale constructed wetland with different depth. Bioresour Technol 100: 2945-2951. doi: 10.1016/j.biortech.2009.01.045
    [42] Verlicchi P, Galletti A, Petrovic M, et al. (2013) Removal of selected pharmaceuticals from domestic wastewater in an activated sludge system followed by a horizontal subsurface flow bed-Analysis of their respective contributions. Sci Total Environ 454-455: 411-425. doi: 10.1016/j.scitotenv.2013.03.044
    [43] Song H-L, Yang X-L, Nakano K, et al. (2011) Elimination of estrogens and estrogenic activity from sewage treatment works effluents in subsurface and surface flow constructed wetlands. Int J Environ Anal Chem 91: 600-614. doi: 10.1080/03067319.2010.496046
    [44] Hu X, Bao Y, Hu J, et al. (2017) Occurrence of 25 pharmaceuticals in Taihu Lake and their removal from two urban drinking water treatment plants and a constructed wetland. Env Sci Pollut Res 24: 14889-14902. doi: 10.1007/s11356-017-8830-y
    [45] Kimura K, Hara H, Watanabe Y (2007) Elimination of selected acidic pharmaceuticals from municipal wastewater by an activated sludge system and membrane bioreactors. Environ Sci Technol 41: 3708-3714. doi: 10.1021/es061684z
    [46] Fazal S, Zhang B, Zhong Z, et al. (2015) Industrial Wastewater Treatment by Using MBR (Membrane Bioreactor) Review Study. J Environ Prot (Irvine, Calif) 06: 584-598. doi: 10.4236/jep.2015.66053
    [47] Carmosini N, Lee LS (2009) Ciprofloxacin sorption by dissolved organic carbon from reference and bio-waste materials. Chemosphere 77: 813-820. doi: 10.1016/j.chemosphere.2009.08.003
    [48] Zuehlke S, Duennbier U, Lesjean B, et al. (2006) Long-Term Comparison of Trace Organics Removal Performances Between Conventional and Membrane Activated Sludge Processes. Water Environ Res 78: 2480-2486. doi: 10.2175/106143006X111826
    [49] Baumgarten S (2007) Membranbioreaktoren zur industriellen Abwasserreinigung.
    [50] Janssens R, Mandal MK, Dubey KK, et al. (2017) Slurry photocatalytic membrane reactor technology for removal of pharmaceutical compounds from wastewater: Towards cytostatic drug elimination. Sci Total Environ 599-600: 612-626. doi: 10.1016/j.scitotenv.2017.03.253
    [51] Abass OK, Wu X, Guo Y, et al. (2015) Membrane Bioreactor in China: A Critical Review. Int J Membr Sci Technol 2: 29-47. doi: 10.15379/2410-1869.2015.02.02.04
    [52] Besha AT, Gebreyohannes AY, Tufa RA, et al. (2017) Removal of emerging micropollutants by activated sludge process and membrane bioreactors and the effects of micropollutants on membrane fouling: A review. J Environ Chem Eng 5: 2395-2414. doi: 10.1016/j.jece.2017.04.027
    [53] Fan H, Li J, Zhang L, et al. (2014) Contribution of sludge adsorption and biodegradation to the removal of five pharmaceuticals in a submerged membrane bioreactor. Biochem Eng J 88: 101-107. doi: 10.1016/j.bej.2014.04.008
    [54] Kovalova L, Siegrist H, Singer H, et al. (2012) Hospital wastewater treatment by membrane bioreactor: Performance and efficiency for organic micropollutant elimination. Environ Sci Technol 46: 1536-1545. doi: 10.1021/es203495d
    [55] Le T, Ng C, Tran NH, et al. (2018) Removal of antibiotic residues, antibiotic resistant bacteria and antibiotic resistance genes in municipal wastewater by membrane bioreactor systems. Water Res 498-508.
    [56] Zhang W, Ding L, Luo J, et al. (2016) Membrane fouling in photocatalytic membrane reactors (PMRs) for water and wastewater treatment: A critical review. Chem Eng J 302: 446-458. doi: 10.1016/j.cej.2016.05.071
    [57] Huang BC, Guan YF, Chen W, et al. (2017) Membrane fouling characteristics and mitigation in a coagulation-assisted microfiltration process for municipal wastewater pretreatment. Water Res 123: 216-223. doi: 10.1016/j.watres.2017.06.080
    [58] Liébana R, Arregui L, Belda I, et al. (2015) Membrane bioreactor wastewater treatment plants reveal diverse yeast and protist communities of potential significance in biofouling. Biofouling 31: 71-82. doi: 10.1080/08927014.2014.998206
    [59] Oppenländer T (2003) Photochemical Purification of Water and Air: Advanced Oxidation Processes (AOPs): Principles, Reaction Mechanisms, Reactor Concepts (Chemistry), Weinheim, WILEY-VCH Verlag.
    [60] Parsons S (2004) Advanced Oxidation Processes for Water and Wastewater Treatment, London, IWA Publishing.
    [61] Andreozzi R, Caprio V, Insola A, et al. (1999) Advanced oxidation processes (AOP) for water purification and recovery. Catal Today 53: 51-59. doi: 10.1016/S0920-5861(99)00102-9
    [62] Voigt M, Bartels I, Nickisch-hartfiel A, et al. (2018) Elimination of macrolides in water bodies using photochemical oxidation. AIMS Environ Sci 5: 372-388. doi: 10.3934/environsci.2018.5.372
    [63] Homem V, Santos L (2011) Degradation and removal methods of antibiotics from aqueous matrices--a review. J Environ Manage 92: 2304-2347. doi: 10.1016/j.jenvman.2011.05.023
    [64] Monteagudo JM, Durán A, San Martín I (2014) Mineralization of wastewater from the pharmaceutical industry containing chloride ions by UV photolysis of H2O2/Fe(II) and ultrasonic irradiation. J Environ Manage 141: 61-69. doi: 10.1016/j.jenvman.2014.03.020
    [65] Shahidi D, Roy R, Azzouz A (2015) Advances in catalytic oxidation of organic pollutants-Prospects for thorough mineralization by natural clay catalysts. Appl Catal B Environ 174-175: 277-292. doi: 10.1016/j.apcatb.2015.02.042
    [66] Brillas E (2014) A review on the degradation of organic pollutants in waters by UV photoelectro-fenton and solar photoelectro-fenton. J Braz Chem Soc 25: 393-417.
    [67] Voigt M, Bartels I, Nickisch-Hartfiel A, et al. (2017) Photoinduced degradation of sulfonamides, kinetic, and structural characterization of transformation products and assessment of environmental toxicity. Toxicol Environ Chem 99: 1304-1327. doi: 10.1080/02772248.2017.1373777
    [68] Jelic a., Michael I, Achilleos a., et al. (2013) Transformation products and reaction pathways of carbamazepine during photocatalytic and sonophotocatalytic treatment. J Hazard Mater 263: 177-186. doi: 10.1016/j.jhazmat.2013.07.068
    [69] Vasconcelos TG, Henriques DM, König A, et al. (2009) Photo-degradation of the antimicrobial ciprofloxacin at high pH: Identification and biodegradability assessment of the primary by-products. Chemosphere 76: 487-493. doi: 10.1016/j.chemosphere.2009.03.022
    [70] Suslick S, Fang M (1999) Acoustic cavitation and its chemical consequences. Phil Trans R Soc Lond A 335-353.
    [71] Torres-Palma RA, Serna-Galvis EA (2018) Sonolysis, Advanced Oxidation Processes for Waste Water Treatment, Elsevier, 177-213.
    [72] Serna-Galvis EA, Botero-Coy AM, Martínez-Pachón D, et al. (2019) Degradation of seventeen contaminants of emerging concern in municipal wastewater effluents by sonochemical advanced oxidation processes. Water Res 154: 349-360. doi: 10.1016/j.watres.2019.01.045
    [73] Zoschke K, Börnick H, Worch E (2014) Vacuum-UV radiation at 185 nm in water treatment-a review. Water Res 52: 131-145. doi: 10.1016/j.watres.2013.12.034
    [74] Crapulli F, Santoro D, Sasges MR, et al. (2014) Mechanistic modeling of vacuum UV advanced oxidation process in an annular photoreactor. Water Res 64: 209-225. doi: 10.1016/j.watres.2014.06.048
    [75] Heit G, Neuner A, Saugy P, et al. (1998) Vacuum-UV (172 nm) Actinometry. The Quantum Yield of the Photolysis of Water. J Phys Chem A 5639: 5551-5561.
    [76] Ratpukdi T (2014) Degradation of Paracetamol and Norfloxacin in Aqueous Solution Using Vacuum Ultraviolet (VUV) Process. J Clean Energy Technol 2: 168-170.
    [77] Szabó RK, Megyeri C, Illés E, et al. (2011) Phototransformation of ibuprofen and ketoprofen in aqueous solutions. Chemosphere 84: 1658-1663. doi: 10.1016/j.chemosphere.2011.05.012
    [78] Voigt M, Jaeger M (2017) On the photodegradation of azithromycin, erythromycin and tylosin and their transformation products-A kinetic study. Sustain Chem Pharm 5: 131-140. doi: 10.1016/j.scp.2016.12.001
    [79] Gottschalk C, Libra JA, Saupe A (2010) Ozonation of Water and Waste Water-A Practical Guide to Understanding Ozone and its Applications, Weinheim, WILEY-VCH Verlag GmbH & Co. KGaA.
    [80] Antoniou MG, Hey G, Rodríguez Vega S, et al. (2013) Required ozone doses for removing pharmaceuticals from wastewater effluents. Sci Total Environ 456-457: 42-49. doi: 10.1016/j.scitotenv.2013.03.072
    [81] Ribeiro AR, Nunes OC, Pereira MFR, et al. (2015) An overview on the advanced oxidation processes applied for the treatment of water pollutants defined in the recently launched Directive 2013/39/EU. Environ Int 75: 33-51. doi: 10.1016/j.envint.2014.10.027
    [82] Matilainen A, Sillanpää M (2010) Removal of natural organic matter from drinking water by advanced oxidation processes. Chemosphere 80: 351-365. doi: 10.1016/j.chemosphere.2010.04.067
    [83] Tong L, Eichhorn P, Pérez S, et al. (2011) Photodegradation of azithromycin in various aqueous systems under simulated and natural solar radiation: kinetics and identification of photoproducts. Chemosphere 83: 340-348. doi: 10.1016/j.chemosphere.2010.12.025
    [84] Frontistis Z, Kouramanos M, Moraitis S, et al. (2015) UV and simulated solar photodegradation of 17α-ethynylestradiol in secondary-treated wastewater by hydrogen peroxide or iron addition. Catal Today 252: 84-92. doi: 10.1016/j.cattod.2014.10.012
    [85] Ma X, Zhang C, Deng J, et al. (2015) Simultaneous degradation of estrone, 17β-estradiol and 17α-ethinyl estradiol in an aqueous UV/H2o2 system. Int J Environ Res Public Health 12: 12016-12029. doi: 10.3390/ijerph121012016
    [86] Voigt M, Savelsberg C, Jaeger M (2017) Photodegradation of the antibiotic spiramycin studied by high-performance liquid quadrupole time-of-flight mass spectrometry. Toxicol Environ Chem 99: 624-640. doi: 10.1080/02772248.2017.1280039
    [87] Hernández F, Bakker J, Bijlsma L, et al. (2019) The role of analytical chemistry in exposure science: Focus on the aquatic environment. Chemosphere 564-583.
    [88] Voigt M, Savelsberg C, Jaeger M (2018) Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation. J Vis Exp.
    [89] Bobu M, Yediler A, Siminiceanu I, et al. (2013) Comparison of different advanced oxidation processes for the degradation of two fluoroquinolone antibiotics in aqueous solutions. J Environ Sci Heal Part A 48: 251-262.
    [90] Yu F, Li Y, Han S, et al. (2016) Adsorptive removal of antibiotics from aqueous solution using carbon materials. Chemosphere 153: 365-385. doi: 10.1016/j.chemosphere.2016.03.083
    [91] Sharif F, Westerhoff P, Herckes P (2013) Sorption of trace organics and engineered nanomaterials onto wetland plant material. Environ Sci Process Impacts 15: 267-274. doi: 10.1039/C2EM30613A
    [92] Gao Y, Li Y, Zhang L, et al. (2012) Adsorption and removal of tetracycline antibiotics from aqueous solution by graphene oxide. J Colloid Interface Sci 368: 540-546. doi: 10.1016/j.jcis.2011.11.015
    [93] Mailler R, Gasperi J, Coquet Y, et al. (2016) Removal of emerging micropollutants from wastewater by activated carbon adsorption: Experimental study of different activated carbons and factors influencing the adsorption of micropollutants in wastewater. J Environ Chem Eng 4: 1102-1109. doi: 10.1016/j.jece.2016.01.018
    [94] Kaub M, Biebersdorf N (2014) Kläranlage Höxter 4. Reinigungsstufe zur Elimination von Mikroschadstoffen, Bochum.
    [95] Grover DP, Zhou JL, Frickers PE, et al. (2011) Improved removal of estrogenic and pharmaceutical compounds in sewage effluent by full scale granular activated carbon : Impact on receiving river water. J Hazard Mater 185: 1005-1011. doi: 10.1016/j.jhazmat.2010.10.005
    [96] Kovalova L, Siegrist H, Von Gunten U, et al. (2013) Elimination of micropollutants during post-treatment of hospital wastewater with powdered activated carbon, ozone, and UV. Environ Sci Technol 47: 7899-7908. doi: 10.1021/es400708w
    [97] Mailler R, Gasperi J, Coquet Y, et al. (2016) Removal of a wide range of emerging pollutants from wastewater treatment plant discharges by micro-grain activated carbon in fluidized bed as tertiary treatment at large pilot scale. Sci Total Environ 542: 983-996. doi: 10.1016/j.scitotenv.2015.10.153
    [98] Lima DRS, Baêta BEL, Aquino SF, et al. (2014) Removal of Pharmaceuticals and Endocrine Disruptor Compounds from Natural Waters by Clarification Associated with Powdered Activated Carbon. Water Air Soil Pollut 225.
    [99] Rubirola A, Llorca M, Rodriguez-Mozaz S, et al. (2014) Characterization of metoprolol biodegradation and its transformation products generated in activated sludge batch experiments and in full scale WWTPs. Water Res 63: 21-32. doi: 10.1016/j.watres.2014.05.031
    [100] Kårelid V, Larsson G, Björlenius B (2017) Pilot-scale removal of pharmaceuticals in municipal wastewater: Comparison of granular and powdered activated carbon treatment at three wastewater treatment plants. J Environ Manage 193: 491-502. doi: 10.1016/j.jenvman.2017.02.042
    [101] Li L, Quinlivan PA, Knappe DRU (2002) Effects of activated carbon surface chemistry and pore structure on the adsorption of organic contaminants from aqueous solution. Carbon N Y 40: 2085-2100. doi: 10.1016/S0008-6223(02)00069-6
    [102] Benstoem F, Nahrstedt A, Boehler M, et al. (2017) Performance of granular activated carbon to remove micropollutants from municipal wastewater-A meta-analysis of pilot- and large-scale studies. Chemosphere 185: 105-118. doi: 10.1016/j.chemosphere.2017.06.118
    [103] Margot J, Magnet A (2011) Elimination des micropolluants dans les eaux usées-Essais pilotes à la station d épuration de Lausanne. gwa 7: 487-493.
    [104] Margot J, Kienle C, Magnet A, et al. (2013) Treatment of micropollutants in municipal wastewater: Ozone or powdered activated carbon? Sci Total Environ 461-462: 480-498. doi: 10.1016/j.scitotenv.2013.05.034
    [105] Baresel C, Malmborg J, Ek M, et al. (2016) Removal of pharmaceutical residues using ozonation as intermediate process step at Linköping WWTP, Sweden. Water Sci Technol 73: 2017-2024. doi: 10.2166/wst.2016.045
    [106] Mamo J, Insa S, Monclús H, et al. (2016) Fate of NDMA precursors through an MBR-NF pilot plant for urban wastewater reclamation and the effect of changing aeration conditions. Water Res 102: 383-393. doi: 10.1016/j.watres.2016.06.057
    [107] Hofman-Caris CHM, Siegers WG, van de Merlen K, et al. (2017) Removal of pharmaceuticals from WWTP effluent: Removal of EfOM followed by advanced oxidation. Chem Eng J 327: 514-521. doi: 10.1016/j.cej.2017.06.154
    [108] Cédat B, de Brauer C, Métivier H, et al. (2016) Are UV photolysis and UV/H 2 O 2 process efficient to treat estrogens in waters? Chemical and biological assessment at pilot scale. Water Res 100: 357-366.
    [109] El-taliawy H, Ekblad M, Nilsson F, et al. (2017) Ozonation efficiency in removing organic micro pollutants from wastewater with respect to hydraulic loading rates and different wastewaters. Chem Eng J 325: 310-321. doi: 10.1016/j.cej.2017.05.019
    [110] Ibáñez M, Borova V, Boix C, et al. (2017) UHPLC-QTOF MS screening of pharmaceuticals and their metabolites in treated wastewater samples from Athens. J Hazard Mater 323: 26-35. doi: 10.1016/j.jhazmat.2016.03.078
  • This article has been cited by:

    1. Melanie Voigt, Nils Wellen, Jean-Michel Dluziak, Victoria Langerbein, Martin Jaeger, Photoinduced degradation of three azole compounds from 3rd EU watchlist monitored by high-resolution higher-order mass spectrometry – Part I: A mechanistic study, 2022, 9, 26667657, 100288, 10.1016/j.envadv.2022.100288
    2. Melanie Voigt, Victoria Langerbein, Jean-Michel Dluziak, Nils Wellen, Martin Jaeger, The role of the direct and indirect mechanism in the advanced oxidation process induced degradation of ciprofloxacin, 2023, 0277-2248, 1, 10.1080/02772248.2023.2168005
    3. Lara Wöhler, Arjen Y. Hoekstra, Rick J. Hogeboom, Marcela Brugnach, Maarten S. Krol, Alternative societal solutions to pharmaceuticals in the aquatic environment, 2020, 277, 09596526, 124350, 10.1016/j.jclepro.2020.124350
    4. Melanie Voigt, Indra Bartels, Dorothee Schmiemann, Lars Votel, Kerstin Hoffmann-Jacobsen, Martin Jaeger, Metoprolol and Its Degradation and Transformation Products Using AOPs—Assessment of Aquatic Ecotoxicity Using QSAR, 2021, 26, 1420-3049, 3102, 10.3390/molecules26113102
    5. F.J. Lopez, E. Pitarch, A.M. Botero-Coy, D. Fabregat-Safont, M. Ibáñez, J.M. Marin, A. Peruga, N. Ontañón, S. Martínez-Morcillo, A. Olalla, Y. Valcárcel, I. Varó, F. Hernández, Removal efficiency for emerging contaminants in a WWTP from Madrid (Spain) after secondary and tertiary treatment and environmental impact on the Manzanares River, 2022, 812, 00489697, 152567, 10.1016/j.scitotenv.2021.152567
    6. Dorothee Schmiemann, Lisa Hohenschon, Indra Bartels, Andrea Hermsen, Felix Bachmann, Arno Cordes, Martin Jäger, Jochen Stefan Gutmann, Kerstin Hoffmann-Jacobsen, Enzymatic post-treatment of ozonation: laccase-mediated removal of the by-products of acetaminophen ozonation, 2023, 1614-7499, 10.1007/s11356-023-25913-w
    7. Sutrisno Salomo Hutagalung, Ande Fudja Rafryanto, Wei Sun, Nurochma Juliasih, Sri Aditia, Jizhou Jiang, Hermawan Kresno Dipojono, Sri Harjati Suhardi, Nurul Taufiqu Rochman, Deddy Kurniadi, Combination of ozone-based advanced oxidation process and nanobubbles generation toward textile wastewater recovery, 2023, 11, 2296-665X, 10.3389/fenvs.2023.1154739
    8. Melanie Voigt, Nils Wellen, Jean-Michel Dluziak, Victoria Langerbein, Martin Jaeger, Photoinduced Degradation Of Three Azole Compounds from 3rd Eu Watchlist Monitored by High-Resolution Higher-Order Mass Spectrometry – Part I:  A Mechanistic Study, 2022, 1556-5068, 10.2139/ssrn.4102799
    9. Kornelia Smalla, Jan Kabisch, Gregor Fiedler, Jens Andre Hammerl, Bernd-Alois Tenhagen, Gesundheitsrisiken durch die Bewässerung von Nutzpflanzen mit aufbereitetem Abwasser, das Antibiotikarückstände, Resistenzgene und resistente Mikroorganismen enthält, 2023, 66, 1436-9990, 660, 10.1007/s00103-023-03710-7
    10. Jordana Georgin, Dison Stracke Pfingsten Franco, Mohammad Saood Manzar, Lucas Meili, Noureddine El Messaoudi, A critical and comprehensive review of the current status of 17β-estradiol hormone remediation through adsorption technology, 2024, 31, 1614-7499, 24679, 10.1007/s11356-024-32876-z
    11. Melanie Voigt, Jean-Michel Dluziak, Nils Wellen, Martin Jaeger, Mechanistic study of the electrochemical oxidation of fluoroquinolones: Ciprofloxacin, danofloxacin, enoxacin, levofloxacin and lomefloxacin, 2024, 355, 00456535, 141763, 10.1016/j.chemosphere.2024.141763
    12. Melanie Voigt, Martin Jaeger, 2023, 9780443153396, 495, 10.1016/B978-0-443-15339-6.00018-7
    13. Melanie Voigt, Martin Jaeger, Efficiency increased advanced oxidation processes by persalts for the elimination of pharmaceuticals in waterbodies: a short review, 2024, 4, 2730-7700, 10.1007/s43938-024-00052-x
    14. Zhuo Gao, Ignacio Sanjuán, Ulrich Hagemann, Alexandra S. M. Wittmar, Corina Andronescu, Mathias Ulbricht, Polyacrylonitrile‐based porous polymer spheres and their conversion to N‐doped carbon materials for adsorption and electrocatalysis, 2024, 141, 0021-8995, 10.1002/app.55438
    15. Melanie Voigt, Nils Wellen, Jean-Michel Dluziak, Victoria Langerbein, Martin Jaeger, Photoinduced Degradation of Three Azole Compounds from 3rd EU Watchlist Monitored by High-Resolution Higher-Order Mass Spectrometry – Part I: A Mechanistic Study, 2022, 1556-5068, 10.2139/ssrn.4181211
    16. Melanie Voigt, Jean-Michel Dluziak, Nils Wellen, Victoria Langerbein, Martin Jaeger, Comparison of photoinduced and electrochemically induced degradation of venlafaxine, 2024, 31, 1614-7499, 13442, 10.1007/s11356-024-32018-5
    17. Meilia Tarigan, Samir Raji, Heyam Al-Fatesh, Peter Czermak, Mehrdad Ebrahimi, The Occurrence of Micropollutants in the Aquatic Environment and Technologies for Their Removal, 2025, 13, 2227-9717, 843, 10.3390/pr13030843
  • Reader Comments
  • © 2020 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(11429) PDF downloads(706) Cited by(17)

Figures and Tables

Figures(13)  /  Tables(8)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog